Transplacental transfer of Remdesivir and GS-441524: An ex vivo perfusion study

被引:0
|
作者
Louchet, Margaux [1 ]
Ribot, Megane [1 ]
Bouazza, Naim [2 ]
Foissac, Frantz [2 ]
Froelicher, Leo [1 ]
Buth, Victoria [3 ]
Benaboud, Sihem [1 ]
Treluyer, Jean-Marc [1 ,2 ,3 ]
Lui, Gabrielle [1 ,3 ,4 ]
机构
[1] Hop Cochin, Serv Pharmacol, Paris, France
[2] Hop Tarnier, AP HP, Unite Rech Clin, Paris, France
[3] CIC 1419 Mere Enfant Cochin Necker, Paris, France
[4] Hop Cochin, Serv Pharmacol, 27 Rue Faubourg St Jacques, F-75014 Paris, France
关键词
ex vivo cotyledon perfusion; GS-441524; placenta; Remdesivir; transplacental transfer; EXPRESSION; GENE;
D O I
10.1002/hsr2.1144
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [41] Exploration for the effect of renal function and renal replacement therapy on pharmacokinetics of remdesivir and GS-441524 in patients with COVID-19: A limited case series
    Choe, Pyoeng Gyun
    Jeong, Sae Im
    Kang, Chang Kyung
    Yang, Liju
    Lee, SeungHwan
    Cho, Joo-Youn
    Han, Seung Seok
    Kim, Dong Ki
    Lee, Sang Min
    Park, Wan Beom
    Oh, Myoung-Don
    Kim, Nam Joong
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022, 15 (03): : 732 - 740
  • [42] Combination of the parent analogue of remdesivir (GS-441524) and molnupiravir results in a markedly potent antiviral effect in SARS-CoV-2 infected Syrian hamsters
    Abdelnabi, Rana
    Maes, Piet
    de Jonghe, Steven
    Weynand, Birgit
    Neyts, Johan
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [43] An Optimized Bioassay for Screening Combined Anticoronaviral Compounds for Efficacy against Feline Infectious Peritonitis Virus with Pharmacokinetic Analyses of GS-441524, Remdesivir, and Molnupiravir in Cats
    Cook, Sarah
    Wittenburg, Luke
    Yan, Victoria C.
    Theil, Jacob H.
    Castillo, Diego
    Reagan, Krystle L.
    Williams, Sonyia
    Pham, Cong-Dat
    Li, Chun
    Muller, Florian L.
    Murphy, Brian G.
    VIRUSES-BASEL, 2022, 14 (11):
  • [44] Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model
    Chiba, Shiho
    Kiso, Maki
    Nakajima, Noriko
    Iida, Shun
    Maemura, Tadashi
    Kuroda, Makoto
    Sato, Yuko
    Ito, Mutsumi
    Okuda, Moe
    Yamada, Shinya
    Iwatsuki-Horimoto, Kiyoko
    Watanabe, Tokiko
    Imai, Masaki
    Armbrust, Tammy
    Baric, Ralph S.
    Halfmann, Peter J.
    Suzuki, Tadaki
    Kawaoka, Yoshihiro
    MBIO, 2022, 13 (01):
  • [45] Owner experience and veterinary involvement with unlicensed GS-441524 treatment of feline infectious peritonitis: a prospective cohort study
    Negash, Rosa
    Li, Emma
    Jacque, Nicole
    Novicoff, Wendy
    Evans, Samantha J. M.
    FRONTIERS IN VETERINARY SCIENCE, 2024, 11
  • [46] Nonsteroidal anti-inflammatory drugs (NSAIDs) and nucleotide analog GS-441524 conjugates with potent in vivo efficacy against coronaviruses
    Zhou, Qifan
    Luo, Yinzhu
    Zhu, Yujun
    Chen, Qishu
    Qiu, Jingfei
    Cong, Feng
    Li, Yingjun
    Zhang, Xumu
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 249
  • [47] Study of transplacental transfer of taxanes using the human ex vivo perfused cotyledon model
    Vinot, C.
    Giraud, C.
    Rezai, K.
    Peytavin, G.
    Urien, S.
    Gavard, L.
    Mandelbrot, L.
    Treluyer, J. M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 109 - 109
  • [48] Validation of LC-MS/MS methods for determination of remdesivir and its metabolites GS-441524 and GS-704277 in acidified human plasma and their application in COVID-19 related clinical studies
    Xiao, Deqing
    Ling, Kah Hiing John
    Tarnowski, Thomas
    Humeniuk, Rita
    German, Polina
    Mathias, Anita
    Chu, Jasper
    Chen, Yuan-Shek
    van Ingen, Eric
    ANALYTICAL BIOCHEMISTRY, 2021, 617
  • [49] Role of OATP4C1 in Renal Handling of Remdesivir and its Nucleoside Analog GS-441524: The First Approved Drug for Patients with COVID-19
    Sato, Toshihiro
    Maekawa, Masamitsu
    Mano, Nariyasu
    Abe, Takaaki
    Yamaguchi, Hiroaki
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2021, 24 : 227 - 236
  • [50] The triple combination of Remdesivir (GS-441524), Molnupiravir and Ribavirin is highly efficient in inhibiting coronavirus replication in human nasal airway epithelial cell cultures and in a hamster infection model
    Do, Thuc Nguyen Dan
    Abdelnabi, Rana
    Boda, Bernadett
    Constant, Samuel
    Neyts, Johan
    Jochmans, Dirk
    ANTIVIRAL RESEARCH, 2024, 231